Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trapani

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
Diabetes|July 23, 2017
Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent PathwayZia U A Mollah, Hong Sheng Quah, Kate L Graham, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Nature|August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunityMarian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Nature Communications|May 14, 2021
Antigen-driven EGR2 expression is required for exhausted CD8<sup>+</sup> T cell stability and maintenanceMayura V Wagle, Stephin J Vervoort, Madison J Kelly, et al.
Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.
Science (New York, N.Y.)|August 25, 2007
A common fold mediates vertebrate defense and bacterial attackCarlos J Rosado, Ashley M Buckle, Ruby H P Law, et al.
Immunity|May 22, 2024
The CD8<sup>+</sup> T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsWillem Van Der Byl, Simone Nüssing, Timothy J Peters, et al.
Nature Immunology|June 8, 2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaNicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Diabetes|July 23, 2017
Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent PathwayZia U A Mollah, Hong Sheng Quah, Kate L Graham, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Nature|August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunityMarian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Nature Communications|May 14, 2021
Antigen-driven EGR2 expression is required for exhausted CD8<sup>+</sup> T cell stability and maintenanceMayura V Wagle, Stephin J Vervoort, Madison J Kelly, et al.
Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.
Science (New York, N.Y.)|August 25, 2007
A common fold mediates vertebrate defense and bacterial attackCarlos J Rosado, Ashley M Buckle, Ruby H P Law, et al.
Immunity|May 22, 2024
The CD8<sup>+</sup> T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsWillem Van Der Byl, Simone Nüssing, Timothy J Peters, et al.
Nature Immunology|June 8, 2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaNicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Pageof 36